Symptom Based Treatment Affects Brain Plasticity - the Role of Verbal Auditory Hallucinations
NCT ID: NCT02722915
Last Updated: 2020-01-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
81 participants
INTERVENTIONAL
2016-07-31
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Symptom Based Treatment Affects Brain Plasticity - Cognitive Training in Patients With Affective Symptoms
NCT03183947
Auditory Beat Stimulation and Behavioural Variant of Frontotemporal Dementia
NCT05917886
fMRI-based Neurofeedback to Relieve Drug-resistant Auditory Hallucinations
NCT04798131
In-depth Investigation of Brain Network Interactions
NCT04748146
Compensatory Brain Mechanisms for Amygdala-associated Cognitive Dysfunction: Potential Role of the Cortical Mirror Neuron System
NCT03723733
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
AVH are a key symptom of schizophrenia. They limit social functions significantly and are resistant to the therapy with antipsychotics in 25 % of cases. AVH also occur in 6-15 % of the healthy population, without meeting any diagnostic criteria for schizophrenia or other psychiatric disorders. This study will perform a direct, not-invasive and selective modulation of networks underlying AVH and assess their neural, cognitive and emotional effects. The focus of this study is on the connectivity between auditory cortex and inferior frontal cortex. Various studies demonstrated that the auditory cortex exhibits an abnormal function in schizophrenia patients. It was shown that during AVH, auditory cortex (superior temporal lobe) and inferior frontal cortex synchronize spontaneously. These regions play an essential role in speech perception and processing. An increased synchronisation of these areas could lead to the development of AVH. This study will try to reduce frontotemporal connectivity to uncouple the regions. Increasing connectivity of both areas will serve as control condition and furthermore intensify the perceived control of the own brain activity and of the associated AVH. Thus, patients will learn which factors influence the appearance of their hallucinations.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
fMRI Neurofeedback up-regulation
Study related procedures included: PANAS, AVHRS, SF 36 (questionnaires or evaluations)
fMRI
collection of functional brain data for 1 hour per day
Neurofeedback
Task of the participants is to increase or decrease the connectivity between selected brain regions in double-blind, randomized order. After the regulation they will get a feedback about the regulation success. (Patients and controls with AVH: days 3 \& 4; controls without AVH: Days 2 \& 3)
PANAS
to assess the mood before and after the fMRI and after 1 week during a telephone interview
AVHRS
to assess the intensity and quality of the hallucinations before and after the fMRI and after 1 week during a telephone interview
SF36
questionnaire about life quality after 1 week during a telephone interview
fMRI Neurofeedback down-regulation
Study related procedures included: PANAS, AVHRS, SF 36 (questionnaires or evaluations)
fMRI
collection of functional brain data for 1 hour per day
Neurofeedback
Task of the participants is to increase or decrease the connectivity between selected brain regions in double-blind, randomized order. After the regulation they will get a feedback about the regulation success. (Patients and controls with AVH: days 3 \& 4; controls without AVH: Days 2 \& 3)
PANAS
to assess the mood before and after the fMRI and after 1 week during a telephone interview
AVHRS
to assess the intensity and quality of the hallucinations before and after the fMRI and after 1 week during a telephone interview
SF36
questionnaire about life quality after 1 week during a telephone interview
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
fMRI
collection of functional brain data for 1 hour per day
Neurofeedback
Task of the participants is to increase or decrease the connectivity between selected brain regions in double-blind, randomized order. After the regulation they will get a feedback about the regulation success. (Patients and controls with AVH: days 3 \& 4; controls without AVH: Days 2 \& 3)
PANAS
to assess the mood before and after the fMRI and after 1 week during a telephone interview
AVHRS
to assess the intensity and quality of the hallucinations before and after the fMRI and after 1 week during a telephone interview
SF36
questionnaire about life quality after 1 week during a telephone interview
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Fluent German language skills
Exclusion Criteria
* severe affective disorder
* any contraindication to MRI examination or claustrophobia
* pregnant or lactating women
* traumatic brain lesions
* acute physical or neurological impairments
* acute suicidal tendency
* Lack of informed consent
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
RWTH Aachen University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Klaus Mathiak, Prof MD PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital RWTH Aachen, Department of Psychiatry, Psychotherapy and Psychosomatics
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital RWTH Aachen, Department of Psychiatry, Psychotherapy and Psychosomatics
Aachen, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
15-139
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.